178 filings
Page 6 of 9
8-K
1lvw0i7lyjssel2 jl
5 Jan 18
Entry into a Material Definitive Agreement
12:00am
8-K
2vy94lc3 0thfp3aru6
28 Dec 17
Other Events
12:00am
8-K
od873ng
1 Dec 17
Intercept Pharmaceuticals Appoints Christian Weyer as Executive Vice President of Research & Development
12:00am
8-K
j3xuwx
7 Nov 17
Departure of Directors or Certain Officers
12:00am
8-K
h401yswg h21w5sl
1 Nov 17
Intercept Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update
12:00am
8-K
tjrea2r
31 Jul 17
Intercept Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Business Update
12:00am
8-K
72wd1olqvu3mmgi9xlr8
30 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
zgxjre0747kqsfis16qg
4 May 17
Intercept Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Business Update
12:00am
8-K
i59db9d2z024elj
23 Feb 17
Intercept Pharmaceuticals Reports Full Year 2016 Financial Results and Provides Business Update
12:00am
8-K
09yrcn1rmir2bq7pxkbh
9 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
4m1i2qb8i
3 Nov 16
Intercept Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Business Update
12:00am
8-K
0a62ozl72g2fe
13 Oct 16
Departure of Directors or Certain Officers
12:00am
8-K
3wnz3h2he6z4
12 Sep 16
Other Events
12:00am
8-K
ctwhpt2
18 Aug 16
Entry into a Material Definitive Agreement
12:00am
8-K
2u2sm7q0c4f2pi vp2gm
4 Aug 16
Intercept Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Business Update
12:00am
8-K
1tt6dw3bg
22 Jul 16
Entry into a Material Definitive Agreement
12:00am
8-K
lfah2
11 Jul 16
Departure of Directors or Certain Officers
12:00am
8-K
mfhja79hxw6w rqgu
6 Jul 16
Intercept Pharmaceuticals Announces Pricing of Public Offering of Convertible Senior Notes
12:00am
8-K
cuzp0100i6vwpxys2ba3
28 Jun 16
Departure of Directors or Certain Officers
12:00am
8-K
ww9lkdvw2766nnogm
10 Jun 16
Intercept Pharmaceuticals Appoints Sandip Kapadia as Chief Financial Officer
12:00am